Gilead Sciences, Inc. (GILD) Tops Q4 EPS by 2c
Tweet Send to a FriendGet Alerts GILD Hot Sheet
Price: $50.60 -2.58%
Revenue Growth %: +11.0%
Financial Fact:
Net income: 717.71M
Today's EPS Names:
CEDU, CHC, CIDM, More
Revenue Growth %: +11.0%
Financial Fact:
Net income: 717.71M
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade GILD Now!
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q4 EPS of $0.50, $0.02 better than the analyst estimate of $0.48. Revenue for the quarter came in at $2.59 billion versus the consensus estimate of $2.43 billion.
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
- CytoDyn Inc. Appoints Anthony D. Caracciolo as Chairman of the Board of Directors
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
